有恶臭
发表于 2025-3-27 00:59:58
http://image.papertrans.cn/i/image/461693.jpg
亲密
发表于 2025-3-27 02:05:54
Response to Treatment: The Role of Imagingsses for some forms of cancer—resulting in a 1% annual decline in mortality from all cancers in the USA since 1990—each year, about 7 million people worldwide and 600,000 in the USA continue to die from this disease .
Aphorism
发表于 2025-3-27 08:12:10
Surrogate Endpoints of Clinical Benefit and, of course, a high priority for patients and society. Similar to the HIV/AIDS community, there have been numerous efforts to accelerate approvals of new drugs but also to shorten the times required in their development and marketing, with positive as well as negative consequences.
网络添麻烦
发表于 2025-3-27 11:39:13
Renal Canceross, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20–30% of patients with RCC and about 20–30% of all RCC patients have metastatic disease.
inquisitive
发表于 2025-3-27 16:00:52
Hepatocellular Carcinomaiated with liver cirrhosis and chronic infection/chronic hepatitis from viral B and C hepatitis but toxic/metabolic diseases (alcohol abuse, hemochromatosis, and nonalcoholic steatohepatitis associated with obesity and diabetes) seem to be closely linked to a higher risk of developing HCC .
bioavailability
发表于 2025-3-27 18:27:44
http://reply.papertrans.cn/47/4617/461693/461693_36.png
飞行员
发表于 2025-3-28 00:04:23
Book 2012 criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging. These guidelines have been rapidly adopted in clinical practice to monitor patient treatment and for therapy planning. However, relying only on anatomical information is not always s
新字
发表于 2025-3-28 05:08:04
http://reply.papertrans.cn/47/4617/461693/461693_38.png
急性
发表于 2025-3-28 06:20:23
Pancreatic Cancerine therapy and as the reference treatment arm for clinical trials in this patient population . However, its anti-tumoral activity is disappointing because the response rate is around 10%, median survival about 6 months, and 1-year OS around 20%.
连系
发表于 2025-3-28 10:32:11
http://reply.papertrans.cn/47/4617/461693/461693_40.png